Part D Drug Discount Data Is Not Commercial Tool, CMS' Blum Says

The Centers for Medicaid and Medicare Services is wary about drug industry requests for detailed, claims-level information to support invoices on the drug discounts given to Medicare Part D beneficiaries who have reached the coverage gap